Related Experiment Video
Updated: Aug 6, 2026
Brain Pericyte Calcium and Hemodynamic Imaging in Transgenic Mice In Vivo
Published on: November 20, 2021
In vivo evidence that an adenylate cyclase-cAMP system dilates cerebral arterioles in mice
1Department of Pathology (Neuropathology), Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
Abstract:
Pial arterioles of living mice anesthetized with urethane were monitored by television microscopy. I tested the existence of an adenylate cyclase-cyclic adenosine monophosphate (cAMP) system for dilating the arterioles by topically applying the following drugs: cAMP (10(-3) M), its more potent analogue dibutyryl cAMP (10(-3) and 10(-4) M), and forskolin (10(-6) M). Forskolin activates endogenous adenylate cyclase, which leads to increases in endogenous cAMP. Each drug was applied for 30 seconds; all three produced dilation. I then applied either cAMP or forskolin in the presence or absence of 10(-4) M isobutylmethylxanthine (IMX), an inhibitor of endogenous phosphodiesterase, which destroys cAMP. The presence of IMX significantly potentiated the dilation produced by exogenous cAMP and forskolin. These data indicate that cerebral surface arterioles of mice respond to cAMP with dilation and contain the enzymes for producing and inactivating this dilator. The existence of an adenylate cyclase-cAMP dilating mechanism in pial arterioles does not rule out the simultaneous existence of other dilating mechanisms.
Insights
Cerebral arterioles in mice dilate in response to cyclic adenosine monophosphate (cAMP). This study confirms a cAMP-mediated dilation mechanism in pial arterioles, involving adenylate cyclase and phosphodiesterase enzymes.
Area of Science:
- Neuroscience
- Vascular Biology
- Pharmacology
Background:
- Pial arterioles are critical for regulating cerebral blood flow.
- The role of cyclic adenosine monophosphate (cAMP) in regulating cerebral arteriole diameter is not fully understood.
Purpose of the Study:
- To investigate the existence and function of an adenylate cyclase-cAMP system in mediating the dilation of pial arterioles in mice.
Main Methods:
- Living mice were anesthetized with urethane.
- Pial arterioles were monitored using television microscopy.
- Topical application of cAMP, dibutyryl cAMP, and forskolin was performed.
- The effect of isobutylmethylxanthine (IMX), a phosphodiesterase inhibitor, on drug-induced dilation was assessed.
Main Results:
- Topical application of cAMP, dibutyryl cAMP, and forskolin induced significant dilation of pial arterioles.
- Forskolin treatment led to increased endogenous cAMP levels.
- The presence of IMX potentiated the dilatory effects of both exogenous cAMP and forskolin.
- These findings demonstrate that pial arterioles possess the enzymatic machinery to produce and degrade cAMP.
Conclusions:
- The adenylate cyclase-cAMP pathway plays a significant role in the dilation of cerebral surface arterioles in mice.
- Pial arterioles contain functional enzymes for both the synthesis (adenylate cyclase) and degradation (phosphodiesterase) of cAMP.
- While the cAMP system is identified, other mechanisms for pial arteriole dilation may coexist.
